Xconomy -- San Diego-based Phenomix is history. The one-time highflying IPO candidate has shut down its operations, laid off essentially all of its 45 employees, and only has a skeleton crew left attempting to find someone to continue developing its lead drug candidate for diabetes, Xconomy has learned.